back to top
HomeTags290k

290k

4d Molecular Therapeutics CEO sells $290k in inventory By Investing.com

David Kirn, the Chief Government Officer of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT), has bought a complete of $290,598 price of firm inventory, in accordance...

Most Popular

spot_img